Viewing StudyNCT00074074



Ignite Creation Date: 2024-05-05 @ 11:33 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00074074
Status: COMPLETED
Last Update Posted: 2012-07-16
First Post: 2003-12-10

Brief Title: Infliximab in Treating Patients With Myelodysplastic Syndrome
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Organization: European Organisation for Research and Treatment of Cancer - EORTC

Conditions & Keywords Data

Conditions:
Name
Myelodysplastic Syndromes
Keywords:
Name View
previously treated myelodysplastic syndromes View
refractory anemia with excess blasts View
refractory anemia with ringed sideroblasts View
refractory anemia View
de novo myelodysplastic syndromes View
secondary myelodysplastic syndromes View